DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
基本信息
- 批准号:10089484
- 负责人:
- 金额:$ 59.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceBehavior TherapyBehavioralBehavioral ModelBehavioral ResearchBenchmarkingCaringCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicalClinical TrialsCost Effectiveness AnalysisCounselingDevelopmentDoseEmotionalEnrollmentEvidence based interventionGlareGoalsHIVHealthHealth PolicyHealth ServicesIndividualInformal Social ControlInterventionIntervention TrialLifeLinkLiteratureMasksMental HealthModelingMonitorOutcomeParticipantPatientsPlasmaPoliciesPolicy MakerPopulationPovertyRandomizedReportingResearchResource AllocationResourcesStructureSubgroupTelephoneTestingTimeViralViral Load resultantiretroviral therapybarrier to carebasebehavioral adherencebehavioral clinical trialcostcost effectivenessdesigneffective interventionevidence baseflexibilityfollow up assessmentimplementation interventionimplementation scienceimprovedlongitudinal analysisnovelpatient responsepatient subsetsprimary endpointprogramsresource guidesresponsescale upsecondary outcomeservice providersskillssocialsocial factorssocial structuresubstance usetheoriestherapy adherencetherapy designviral rebound
项目摘要
The proposed research will conduct the first ever dose-determination trial of a behavioral intervention to
improve engagement in HIV care, antiretroviral therapy (ART) adherence and HIV viral suppression. The
trial is designed to inform the implementation of behavioral interventions, including several in CDC’s
Compendium of Evidence-Based Interventions. Behavioral counseling has the flexibility and reach to
overcome numerous challenges to HIV care, including social, emotional, and structural barriers. However,
basic questions of how to best implement and scale-up interventions remain unanswered, such as “how much
intervention is needed to achieve HIV suppression in subgroups of patients facing individual and social
challenges?” There are currently no dose-determination trials in the HIV behavioral intervention
literature to guide implementation decisions and health service policy. In the proposed research we
specifically aim to: (a) determine the minimum effective dose of an evidence-based HIV treatment
engagement and adherence intervention, (b) identify subgroups of patients requiring greater and fewer
intervention resources to achieve and sustain viral suppression, and (c) the costs associated with
intervention dose-response. Participants who are receiving ART and confirmed HIV unsuppressed (>200
copies/mL) will be randomized to either: (a) the dose determination condition of weekly evidence-based
behavioral self-regulation counseling until achieving HIV suppression (<200 copies/mL), or (b) fixed dose
5-weekly sessions of evidence-based behavioral self-regulation counseling sessions. The dose
determination condition adjusts to patient needs and determines the dose to achieve HIV suppression, in
contrast to the fixed dose condition that does not adjust to patient response. The trial is therefore designed
to determine the number of behavioral counseling intervention sessions needed to achieve and sustain
HIV suppression. Once viral suppressed, counseling in the dose-determination condition is suspended. In
contrast, the fixed-dose condition is delivered in five prescribed sessions as disseminated by the CDC.
Follow-up assessments commence for 12-months from baseline with the primary endpoint of 12-month
blood plasma HIV viral load and secondary outcome of ART adherence. Response to counseling is
defined by achieving viral suppression (<200 copies/mL) and non-response is defined by not achieving
viral suppression (>200 copies/mL). Participants in both the dose-determination and fixed-session
conditions who initially respond and rebound to unsuppressed viral load will receive additional counseling
with redose-response monitored and analyzed. Longitudinal analyses will examine intervention dose for
key patient subgroups and dose-response cost-effectiveness analyses to guide resource allocation and
implementation decisions. This research is aimed at informing health policy makers and programmatic
decisions regarding intervention implementation to increase the likelihood of sustained HIV suppression.
这项拟议的研究将进行有史以来第一次行为干预的剂量决定试验
提高对艾滋病毒护理、抗逆转录病毒疗法(ART)坚持和艾滋病毒抑制的参与度。这个
试验旨在为行为干预的实施提供信息,包括疾控中心的几项干预措施
循证干预简编。行为咨询具有灵活性和可达性
克服艾滋病毒护理面临的众多挑战,包括社会、情感和结构障碍。然而,
关于如何最好地实施和扩大干预措施的基本问题仍然没有得到回答,例如“多少
需要干预措施,以实现在面对个人和社会的患者亚群中抑制艾滋病毒
挑战?“目前还没有关于艾滋病毒行为干预的剂量决定试验
指导实施决定和卫生服务政策的文献。在拟议的研究中,我们
具体目的是:(A)确定基于证据的艾滋病毒治疗的最低有效剂量
参与度和依从性干预,(B)确定需要更多和更少的患者亚群
用于实现和维持病毒抑制的干预资源,以及(C)与
干预剂量-反应。接受抗逆转录病毒治疗并确认艾滋病毒未被抑制的参与者(>;200
拷贝数/毫升)将随机分为:(A)每周循证的剂量确定条件
行为自律咨询,直到达到HIV抑制(<;200拷贝/毫升),或(B)固定剂量
每周5次以证据为基础的行为自律咨询会议。剂量
检测条件根据患者的需要进行调整,并确定实现艾滋病毒抑制的剂量,在
与不适应患者反应的固定剂量条件形成对比。因此,设计了这项试验
确定实现和维持所需的行为咨询干预会话的数量
抑制艾滋病病毒。一旦病毒被抑制,剂量决定条件下的咨询就会暂停。在……里面
相比之下,固定剂量的情况是在疾病预防控制中心传播的五次规定会议中提供的。
跟踪评估从基线开始,为期12个月,主要终点为12个月
血浆HIV病毒载量和ART依从性的继发性结局。对咨询的反应是
定义为实现病毒抑制(<;200拷贝/毫升),无应答定义为未实现
病毒抑制(>;200拷贝/毫升)。参加剂量测定和固定会议的人员
最初对未抑制的病毒载量有反应并反弹的情况将接受额外的咨询
并对红糖反应进行监测和分析。纵向分析将检查干预剂量
关键患者亚组和剂量反应成本效益分析,以指导资源分配和
实施决定。这项研究旨在为卫生政策制定者和规划人员提供信息
关于实施干预措施的决定,以增加持续抑制艾滋病毒的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SETH C KALICHMAN其他文献
SETH C KALICHMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SETH C KALICHMAN', 18)}}的其他基金
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
- 批准号:
10526406 - 财政年份:2020
- 资助金额:
$ 59.04万 - 项目类别:
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
- 批准号:
9927041 - 财政年份:2020
- 资助金额:
$ 59.04万 - 项目类别:
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
实施循证行为干预的剂量确定试验
- 批准号:
10318539 - 财政年份:2020
- 资助金额:
$ 59.04万 - 项目类别:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence inStigmatized Environments
在污名化环境中改善艾滋病毒护理保留和抗逆转录病毒治疗依从性的干预措施
- 批准号:
9927034 - 财政年份:2019
- 资助金额:
$ 59.04万 - 项目类别:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence inStigmatized Environments
在污名化环境中改善艾滋病毒护理保留和抗逆转录病毒治疗依从性的干预措施
- 批准号:
10533746 - 财政年份:2019
- 资助金额:
$ 59.04万 - 项目类别:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence inStigmatized Environments
在污名化环境中改善艾滋病毒护理保留和抗逆转录病毒治疗依从性的干预措施
- 批准号:
10300062 - 财政年份:2019
- 资助金额:
$ 59.04万 - 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
- 批准号:
8839974 - 财政年份:2014
- 资助金额:
$ 59.04万 - 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
- 批准号:
9418263 - 财政年份:2014
- 资助金额:
$ 59.04万 - 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
- 批准号:
9326100 - 财政年份:2014
- 资助金额:
$ 59.04万 - 项目类别:
Comparative Effectiveness Trial for Retention-Adherence-Health
保留-依从-健康的比较有效性试验
- 批准号:
8925755 - 财政年份:2014
- 资助金额:
$ 59.04万 - 项目类别:
相似海外基金
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
- 批准号:
480808 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
Miscellaneous Programs
Function of cost bias and effect of cognitive behavior therapy on social anxiety in children and adolescents
成本偏差的作用及认知行为治疗对儿童青少年社交焦虑的影响
- 批准号:
23K02970 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide: A Pilot RCT
辩证行为疗法和数字认知行为疗法相结合治疗自杀高危青少年的失眠:一项试点随机对照试验
- 批准号:
10643478 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans with Social Anxiety Disorder and Comorbid PTSD Symptomatology
一项随机临床试验,比较跨诊断行为疗法与特定障碍心理疗法在患有社交焦虑症和共病 PTSD 症状的退伍军人康复中的作用
- 批准号:
10746930 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.
降低 AD/ADRD 患者老年护理人员的自杀风险:调整、实施和评估辩证行为治疗技能培训干预措施。
- 批准号:
10730708 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
A Randomized control trial of behavior therapy of tics in Japan. Exploring the behavior model of tics.
日本抽动行为治疗的随机对照试验。
- 批准号:
22K13840 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder
行为疗法联合丁丙诺啡治疗阿片类药物使用障碍的作用
- 批准号:
10440820 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10429841 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10656415 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression - supplement
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效 - 补充
- 批准号:
10794868 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别: